A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol
Eine cluster-randomisierte kontrollierte Studie zu einer von Pflegekräften geleiteten, KI-gestützten Prävention und Behandlung von Delir (AI-AntiDelirium) auf Delir auf der Intensivstation: Studienprotokoll
PLOS ONE · 29.02.2024 · 19 (2) · e0298793
DOI: 10.1371/journal.pone.0298793 ↗Auf einen Blick
Das Protokoll beschreibt eine cluster-randomisierte Studie zu AI-AntiDelirium auf Intensivstationen. Geprüft werden soll, ob das Tool die Inzidenz von ICU-Delir und weitere Delir-assoziierte Outcomes verbessert.
Fragestellung
Welchen Einfluss hat AI-AntiDelirium im Vergleich zu PADIS-Leitlinien auf die Inzidenz von ICU-Delir und weitere Delir-assoziierte Outcomes?
Methode
Geplante pragmatische, offene, parallele cluster-randomisierte kontrollierte Studie in 6 ICUs in 2 Tertiärkrankenhäusern in China; 1:1-Randomisierung; Registrierung ChiCTR1900023711.
Schlussfolgerung der Autor:innen
Falls die Studie Wirksamkeit zeigt, könnte AI-AntiDelirium die Inzidenz von ICU-Delir und mehrere weitere Outcomes senken und die Adhärenz des ICU-Pflegepersonals an das ABCDEF-Bundle erhöhen.
Kernaussagen
- Studienprotokoll für AI-AntiDelirium auf 6 Intensivstationen
- Primärer Endpunkt: Inzidenz von ICU-Delir
- Sekundäre Endpunkte umfassen Dauer, Mortalität, Kognition und ADL
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 29.02.2024. Verfasst von Shan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Activities of Daily Living, Delirium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: R&D Program of Beijing Municipal Education Commission.
Themen: Künstliche Intelligenz in der Pflege, Intensivpflege, Delir
Abstract (Originalsprache)
Background
Delirium is a common complication among intensive care unit (ICU) patients that is linked to negative clinical outcomes. However, adherence to the Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS guidelines), which recommend the use of the ABCDEF bundle, is sub-optimal in routine clinical care. To address this issue, AI-AntiDelirium , a nurse-led artificial intelligence-assisted prevention and management tool for delirium, was developed by our research team. Our pilot study yielded positive findings regarding the use of AI-AntiDelirium in preventing patient ICU delirium and improving activities of daily living and increasing intervention adherence by health care staff.
Methods
The proposed large-scale pragmatic, open-label, parallel-group, cluster randomized controlled study will assess the impact of AI-AntiDelirium on the incidence of ICU delirium and delirium-related outcomes. Six ICUs in two tertiary hospitals in China will be randomized in a 1:1 ratio to an AI-AntiDelirium or a PADIS guidelines group. A target sample size of 1,452 ICU patients aged 50 years and older treated in the ICU for at least 24 hours will be included. The primary outcome evaluated will be the incidence of ICU delirium and the secondary outcomes will be the duration of ICU delirium, length of ICU and hospital stay, ICU and in-hospital mortality rates, patient cognitive function, patient activities of daily living, and ICU nurse adherence to the ABCDEF bundle.
Discussion
If this large-scale trial provides evidence of the effectiveness of AI-AntiDelirium , an artificial intelligence-assisted system tool, in decreasing the incidence of ICU delirium, length of ICU and hospital stay, ICU and in-hospital mortality rates, patient cognitive function, and patient activities of daily living while increasing ICU nurse adherence to the ABCDEF bundle, it will have a profound impact on the management of ICU delirium in both research and clinical practice. Clinical trial registration ChiCTR1900023711 (Chinese Clinical Trial Registry).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Nursing, Capital Medical University, Beijing, China.
- Cardiology Department, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Nursing Department, Anzhen Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Ying Wu
Förderung
- R&D Program of Beijing Municipal Education Commission
Zitieren
APA
Zhang, S., Cui, W., Ding, S., Li, X., Zhang, X. W., & Wu, Y. (2024). A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol. PLOS ONE, 19(2), e0298793. https://doi.org/10.1371/journal.pone.0298793
Vancouver
Zhang S, Cui W, Ding S, Li X, Zhang XW, Wu Y. A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol. PLOS ONE. 2024;19(2):e0298793. doi:10.1371/journal.pone.0298793
BibTeX
@article{Zhang2024,
author = {Zhang, Shan and Cui, Wei and Ding, Shu and Li, Xiangyu and Zhang, Xi-Wei and Wu, Ying},
title = {A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0298793},
doi = {10.1371/journal.pone.0298793}
}
EUVIMED